SVA (Sinovac Biotech, Ltd) Stock Analysis - Hedge Fund Holdings

Sinovac Biotech, Ltd (SVA) is a publicly traded the market company. As of May 20, 2026, SVA trades at $0.00 with a market cap of $0 and a P/E ratio of 0.00. SVA moved +0.00% today. Year to date, SVA is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces SVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns SVA stock?

Hedge funds tracked by Rallies that own SVA include Renaissance Technologies. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Sinovac Biotech, Ltd.

SVA Key Metrics

Key financial metrics for SVA
MetricValue
Price$0.00
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Top Hedge Funds Holding SVA

  • Renaissance Technologies holds 1.31M shares of SVA, changed +0.00% as of Jun 30, 2024.

SVA Analyst Consensus

SVA analyst coverage data. Average price target: $0.00.

Common questions about SVA

Who owns SVA stock?
Hedge funds tracked by Rallies that own SVA include Renaissance Technologies. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Sinovac Biotech, Ltd.
Does Rallies show 13F holders for SVA?
Yes. Rallies tracks hedge fund and 13F ownership data for SVA, including fund names, share counts, latest tracked quarter, and position changes when available.
Is SVA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SVA. It does not provide personalized investment advice.
SVA

SVA